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Abstract
Both maternal 25-hydroxyvitamin D(25OHD) status and pre-pregnancy BMI(pBMI) may
influence offspring cardio-metabolic outcomes. Lower 25OHD concentrations have been
observed in women with both low and high pBMIs, but the combined influence of pBMI and
25OHD on offspring cardio-metabolic outcomes is unknown. Therefore, this study investi-
gated the role of pBMI in the association between maternal 25OHD concentration and car-
dio-metabolic outcomes in 5-6 year old children. Data were obtained from the ABCD cohort
study and 1882 mother-child pairs were included. The offspring outcomes investigated
were systolic and diastolic blood pressure, heart rate, BMI, body fat percentage(%BF),
waist-to-height ratio, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, glu-
cose, C-peptide, and insulin resistance(HOMA2-IR). 62% of the C-peptide samples were
below the detection limit and were thus imputed using survival analysis. Models were cor-
rected for maternal and offspring covariates and tested for interaction with pBMI. Interaction
with pBMI was observed in the associations with insulin resistance markers: in offspring of
overweight mothers(25.0kg/m2), a 10 nmol/L increase in maternal 25OHD was associated
with a 0.007(99%CI:-0.01,-0.001) nmol/L decrease in C-peptide and a 0.02(99%CI:-0.03,-
0.004) decrease in HOMA2-IR. When only non-imputed data were analyzed, there was a
trend for interaction in the relationship but the results lost significance. Interaction with pBMI
was not observed for the other outcomes. A 10 nmol/L increase in maternal 25OHD was sig-
nificantly associated with a 0.13%(99%CI:-0.3,-0.003) decrease in %BF after correction for
maternal and child covariates. Thus, intrauterine exposure to both low 25OHD and maternal
overweight may be associated with increased insulin resistance in offspring, while exposure
to low 25OHD in utero may be associated with increased offspring %BF with no interactive
effects from pBMI. Due to the limitations of this study, these results are not conclusive,
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Introduction
Exposure to certain nutritional factors in utero, such as insufficient maternal 25-hydroxyvita-
min D (25OHD), may be related to adverse cardio-metabolic outcomes in offspring [1, 2].
Maternal 25OHD deficiency can occur during pregnancy, in part as a result of fetal demand,
and the prevalence varies from 5 to 67% depending on location, ethnicity, and definition of defi-
ciency [2–4]. Laboratory and observational evidence suggest that an individual’s own 25OHD
status may influence the risk for developing chronic diseases, such as type 2 diabetes mellitus
and cardiovascular disease [3, 5] and some studies suggest that maternal 25OHD status during
gestation also influences this risk in offspring [2, 6, 7]. Therefore it is possible that maternal
25OHD deficiency during gestation contributes to cardio-metabolic abnormalities in offspring,
which then track into adulthood and increase the risk of future chronic disease [2, 3, 8].
Inconsistencies exist in the current literature on maternal 25OHD and offspring cardio-
metabolic outcomes. Low maternal 25OHD has been associated with insulin resistance and
with increased fat mass in young children [4, 9], while other studies have not observed these
relationships [10, 11]. Therefore the relationship between maternal 25OHD status and off-
spring cardio-metabolic outcomes warrants further investigation.
In addition to maternal 25OHD status, pre-pregnancy BMI (pBMI) is also related to fetal
development. Underweight increases the risk of low 25OHD levels in both pregnant and non-
pregnant women [12, 13], and in pregnant women, it increases the risk of intrauterine growth
restriction [14]. Overweight is also associated with low 25OHD levels in both pregnant and
non-pregnant individuals [13, 15], and obesity during gestation is associated with offspring
cardio-metabolic abnormalities [16–18]. Additionally, higher pBMIs are associated with lower
25OHD concentrations in neonatal cord blood indicating that less 25OHD reaches a fetus if
the mother is obese [19, 20].
In the current literature on 25OHD and offspring cardio-metabolic outcomes, limited atten-
tion has been given to the role of pBMI and its potentially non-linear relationship with
25OHD. To the best of our knowledge, no study has investigated interaction with pBMI in
these relationships. Therefore, we aimed to clarify the role of pBMI, as well as address previous
inconsistencies, by testing interaction with pBMI in the association between maternal 25OHD
during gestation and a range of cardio-metabolic outcomes in five to six year old children. We
hypothesized that the combination of low maternal 25OHD during gestation and abnormal
pBMI would contribute to greater abnormalities in early childhood cardio-metabolic outcomes
than would intrauterine exposure to either of these maternal variables separately.
Materials and Methods
Study Design
Data were derived from the Amsterdam Born Children and their Development (ABCD) study,
a prospective observational cohort study that began in 2003 [21]. Between January 2003 and
March 2004, all pregnant women in Amsterdam were invited to complete a questionnaire and
volunteer a blood sample during their first prenatal screening. Mothers were contacted for fol-
low-up when the child from this pregnancy reached five years of age. The participating chil-
dren underwent one-day physical examinations and provided blood samples via finger prick at
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their schools or at local museums in Amsterdam. Maternal exclusion criteria included lack of
data on 25OHD (N = 7) and pBMI (N = 1), and extreme 25OHD values (more than six stan-
dard deviations from the mean) (N = 2). Offspring exclusion criteria included twins or multi-
ples (N = 49), non-fasting children (N = 1), congenital disease (N = 101), metabolic diseases
which included cystic fibrosis, type 1 diabetes mellitus and genetic metabolic disorders such as
familial hypercholesterolemia (N = 3), and lack of data on at least one outcome variable
(N = 536). The final study sample consisted of 1882 mother-child pairs (Fig 1), which was
greater than [4, 9, 10] or comparable [11] to the sample sizes of previous studies on this topic.
Written informed consent was obtained via questionnaire from the participating pregnant
women. At this time, women were also asked for written consent for future follow-up. Of those
mothers who gave written informed consent for follow-up, parents and/or guardians gave con-
sent via questionnaire for their five to six year old child to take part in the health check. The
ABCD study and its informed consent procedure were approved by the medical ethics review
committees of the Academic Medical Centre, Amsterdam and the VU University Medical Cen-
tre, Amsterdam, by the Registration Committee of the Municipality of Amsterdam and by the
Central Committee on Research Involving Human Subjects in the Netherlands.
Independent variables
Maternal 25OHD concentration was measured at the Regional Laboratory of Amsterdam using
an enzyme immunoassay technique (OCTEIA AC-57F1 IDS Ltd, Boldon, UK). The intra and
inter-assay coefficients were 8% and<10%, respectively [13]. No results were unreliable per the
hemolytic, icteric or lipemic index, but two results were excluded as extreme values. These
extreme values were excluded because of the lower reliability of the ELISA test at very high or
very low 25OHD levels. Maternal height and pre-pregnancy weight were obtained from the pre-
natal questionnaire and missing data (3.8% of the data on self-reported height and 9.9% of the
data on self-reported weight) were imputed with a random imputation procedure using linear
regression analysis [22]. Data on height and weight were then used to calculate pBMI.
Dependent variables
Continuous heart rate (HR) was measured with the VU University Ambulatory Monitoring
System (VU-AMS; Amsterdam, The Netherlands) and blood pressure was measured using an
Omron 705 IT device (Omron Healthcare Inc, Bannockburn, IL, USA) after the child was
supine for four minutes [23]. Height was measured to the nearest millimeter with a Leicester
portable height measure (Seca, Hamburg, Germany) and weight was measured to the nearest
100 g with a Marsden M-4102 scale (Oxforshire, UK) [23]. Offspring BMI was calculated from
these measurements. Waist circumference was measured to the nearest millimeter using a Seca
measuring tape halfway between the iliac crest and the costal margin and converted into a
waist-to-height ratio (WHtR). Percentage body fat (%BF) was measured twice after subjects
had emptied their bladders. Measurements were completed in a supine position using tetrapo-
lar bioelectrical impedance analysis (BIA) with the BodyStat 1500 MDD device (BodyStat Inc,
Douglas, UK) and the Kushner equation was used to calculate %BF [23, 24]. This technique
was previously investigated and validated in four to seven year old children [24].
Offspring blood samples were collected using the Lab Anywhere kit (Haarlem, The Nether-
lands) and the samples were analyzed in the Regional Laboratory of Amsterdam [25]. Fasting
concentrations of total cholesterol (TC) (mmol/L), low-density lipoprotein cholesterol
(LDL-C) (mmol/L), high-density lipoprotein cholesterol (HDL-C) (mmol/L), triglycerides
(TG) (mmol/L), glucose (mmol/L), and C-peptide (nmol/L) were measured. Because C-peptide
was below the detection limit of 0.34 nmol/L in 62% of the subjects, survival analysis was used
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Fig 1. Flow chart of study participants. Selection of study sample from data collected for the Amsterdam Born Children and their Development cohort
study. 25OHD = 25-hydroxyvitamin D, pBMI = pre-pregnancy BMI, SD = standard deviation. *Note: Exclusion criteria overlap in some participants. †Note: In
the final study sample, some children completed only the physical exam and some only provided blood samples. As a result the final sample size is greater
than the number of children measured in just the physical exam or just the blood testing component.
doi:10.1371/journal.pone.0133313.g001
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to impute these values. This was completed in previous research on the ABCD cohort, where a
more extensive description of the procedure can be found: in short, imputed C-peptide values
were determined on the basis of child age, gender and BMI using a survival analysis method in
the statistical package R [25, 26] (R Foundation for Statistical Computing, Vienna, Austria).
Insulin resistance (IR) was estimated with a homeostatic model assessment (HOMA2-IR)
score calculated from the C-peptide and glucose concentrations [27].
A total of 13 offspring outcome variables were analyzed and because of correlation between
these measurements, the outcomes were grouped as follows: cardiovascular function (systolic
blood pressure (SBP), diastolic blood pressure (DBP), and HR), adiposity (%BF, WHtR, and
BMI), lipid profile (TC, LDL-C, HDL-C, and TG), and glucose metabolism (glucose, C-peptide,
and HOMA2-IR).
Covariates
Covariates were chosen a priori and their measurement has been previously described [13, 23,
25]. In short, covariates were measured using questionnaires that were completed by mothers
during pregnancy, as well as when children were 3 months old and when children were 5–6
years old. Chosen covariates included maternal ethnicity (Dutch, non-Dutch), maternal educa-
tion (years after primary school), parity (nulliparous, multiparous), maternal age during gesta-
tion (years), smoking during gestation (yes, no), duration of breastfeeding (none,<1, 1–3, 4–6,
or6 months), use of infant vitamin D and/or A-D drops (yes, no), child’s current age (years),
child’s gender, and child’s sedentary time (hours). Cardiovascular function outcomes were also
adjusted for the child’s current height (cm).
Season and maternal vitamin D supplement use were not adjusted for because they are
important determinants of maternal 25OHD status and adjusting for these variables could lead
to overcorrection [9, 28]. Maternal co-morbidities (pre- and gestational diabetes mellitus,
maternal hypertension, pre-eclampsia and eclampsia), and birth weight were not adjusted for
because they are potential mediators [2, 13, 29–31]. Finally, analyses were not corrected for ges-
tational age at sampling: there is conflicting data as to whether 25OHD declines over the course
of pregnancy [32–35], and within our study sample, there was no association between gesta-
tional age at time of sampling and maternal 25OHD concentration.
Statistical Analysis
The demographics of the study sample were analyzed across four 25OHD categories: deficient
(29.9 nmol/L), insufficient (30.0–49.9 nmol/L), and adequate (50.0 nmol/L). These catego-
ries were chosen for consistency with previous research on the ABCD cohort because the defi-
nition of 25OHD deficiency is contentious [13, 36, 37].
Restricted cubic spline (RCS) modelling was used to investigate non-linearity between
maternal 25OHD and pBMI, as well as maternal 25OHD and each offspring outcome. The
relationship between maternal 25OHD and pBMI was modeled with corrections for maternal
covariates (age, education, ethnicity, parity and smoking status). Non-linear models were
tested for significant non-linearity with ANOVA and if significant non-linearity was observed,
the likelihood ratio test and AIC values were used to determine if the non-linear model fit sig-
nificantly better than the linear model. If a non-linear relationship was found between 25OHD
and a given outcome, RCS modelling was used for statistical testing. If non-linearity was not
observed, ordinary least squares linear regression was used for all statistical testing. Model 1
was adjusted for child age and gender (and height for cardiovascular function outcomes). All
remaining covariates were added to model 1 to create model 2. To investigate interaction by
pBMI in model 2, the likelihood ratio test was used to compare a model with pBMI included as
Interaction between Maternal Vitamin D and BMI in Child Health
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a covariate against a model with pBMI included as an interaction term. PBMI was categorized
(underweight (<18.5 kg/m2), normal weight (18.5–24.9 kg/m2), and overweight (25.0 kg/
m2)) to enhance interpretability. A p-value<0.1 was considered a significant difference
between the two models because this is the standard p-value cut-off when investigating interac-
tion to avoid missing a potentially important interacting variable. The better fitting model was
determined by comparing the AIC values. Finally, a two-sided Wald test was used to determine
if the interaction terms were significant for underweight women compared to normal weight
women and for overweight women compared to normal weight women. If no interaction was
observed, pBMI was not added to the models as a covariate because pBMI is likely a determi-
nant of maternal 25OHD [38] and its addition to the models could lead to overcorrection.
Post-hoc analyses were conducted to determine if the results would change substantially
with adjustment for season and maternal vitamin D supplement use, analysis of the Dutch-
only sample, and analysis of the sample excluding women with co-morbidities. Analyses of off-
spring C-peptide and HOMA2-IR were also repeated excluding the imputed C-peptide data.
A Bonferroni correction for multiple outcomes was applied based on the four correlated
outcome groups, which resulted in a p-value<0.0125 as significant (0.05 divided by 4). There-
fore, a p-value<0.01 was treated as significant for simplicity. Normality of the outcome vari-
ables was investigated and appropriate transformations were determined via the Box-Cox
method. Both transformed and untransformed data were analyzed to ensure statistical robust-
ness, while allowing presentation of the untransformed model. Data missing from the covari-
ates included in model 2 were imputed using multivariate imputation by chained equations
(MICE) in R, which utilizes all covariates in the dataset to generate values for missing data
[39]. 5 datasets were generated using MICE and all statistical testing was based on the average
values of these 5 datasets. SPSS version 20 (SPSS Inc, Armonk, NY, USA) and R version 2.13.1
(R Foundation for Statistical Computing, Vienna, Austria) were used for all statistical analyses.
Results
2150 eligible mother-child pairs did not complete follow-up as a result of non-response, leaving
Amsterdam or death. The mothers in this non-response group were younger, less educated,
more often non-Dutch, and were more likely to have smoked during pregnancy (Table 1). Of
those who did complete follow-up, 17.7% of the women had deficient 25OHD levels and 20.7%
had insufficient levels (Table 2). The mean maternal 25OHD concentration in the study sample
was 60.4 nmol/L (interquartile range, 18.9–102.7 nmol/L), which was measured at a mean ges-
tational age of 16.1 weeks. Maternal 25OHD deficiency was more likely if blood samples were
drawn in winter, pBMI was higher, and women were younger, less educated, not Dutch, mul-
tiparous, smokers during pregnancy, and not users of vitamin D supplements. The children of
deficient mothers were generally older and more sedentary. 25OHD deficiency was more prev-
alent in both underweight (26.4%) and overweight (31.5%) women when compared to normal
weight women (13.6%), and the relationship between pBMI and 25OHD was significantly
non-linear (p = 0.002) (Fig 2). In the study sample there were 1426 normal weight, 72 under-
weight and 384 overweight women.
None of the associations between maternal 25OHD and child cardio-metabolic outcomes
were significantly non-linear with the exception of the association with child %BF (Table 3).
Interaction with pBMI was observed for the associations with C-peptide (p = 0.02) and
HOMA2-IR (p = 0.02); the models with interaction terms fit significantly better than the mod-
els without interaction terms on basis of the likelihood ratio test and AIC values. Significant
inverse associations between maternal 25OHD and each of these outcomes were observed in
children born to overweight women. For this group, a 10 nmol/L increase in maternal 25OHD
Interaction between Maternal Vitamin D and BMI in Child Health
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was significantly associated with a 0.007 nmol/L decrease in offspring C-peptide (99%CI:-
0.01,-0.001) and a 0.02 decrease in offspring HOMA2-IR (99%CI:-0.03,-0.004) (Fig 3). No sig-
nificant associations between maternal 25OHD and these two outcomes were found in the chil-
dren of underweight or normal weight women.
No interactions were observed for the remaining cardio-metabolic outcomes. In model 1, a
non-linear, inverse association between maternal 25OHD and %BF was observed, which pla-
teaued at ~75 nmol/L of 25OHD (Fig 4). After correction (model 2), the association between
maternal 25OHD and child %BF was no longer significantly non-linear, but there was a signifi-
cant 0.13% decrease in %BF (99%CI: -0.3, -0.003) per 10 nmol/L increase in maternal 25OHD.
Additionally in model 1, a 10 nmol/L increase in maternal 25OHD was significantly associated
with a 0.21 mmHg lower DBP (99%CI: -0.3, -0.09), a 0.05 kg/m2 lower BMI (99%CI: -0.08,
-0.02), and a 0.001 lower WHtR (99%CI: -0.002, -0.0004) in the children, but these relation-
ships were eliminated after adjustment for confounding (model 2): ethnicity and sedentary
time were responsible for the largest attenuation in the effect sizes.
When the analyses were repeated excluding women with co-morbidities (N = 1635), in the
Dutch only group (N = 1299) or when adjusted for season and vitamin D supplement use, the
association between maternal 25OHD and %BF in model 2 lost significance. Despite this, the
upper limit of the 99% CI just crossed 0 in each of these sensitivity analyses, and the effect sizes
observed in these sensitivity analyses were only slightly attenuated in comparison to the overall
analysis (exclusion of co-morbidities: β:-0.13, 99%CI:-0.3, 0.006; exclusion of non-Dutch eth-
nicity: β:-0.10, 99%CI:-0.3, 0.005; adjustment for season and supplement use: β:-0.10, 99%CI:-
0.3, 0.03). Finally, in the sensitivity analysis of non-imputed C-peptide data (N = 322), the
models with pBMI included as an interaction term did not fit significantly better than the mod-
els with pBMI included as a covariate. However, the Wald test suggested a trend towards inter-
action for overweight women compared to normal weight women (p = 0.2 for C-peptide and
p = 0.14 for HOMA2-IR).
Discussion
This study observed inverse associations between maternal 25OHD and the markers of IR (C-
peptide and HOMA2-IR) in children whose mothers were overweight during pregnancy.
Table 1. Comparison of eligible mothers whose children were suitable for follow-up who either completed (responders) or did not complete fol-
low-up (non-responders).
Variable N Responders
(N = 1882)
Non-responders
(N = 2150)
P-value†
Mean SD Mean SD
25OHD 4032 60.4 0.7 52.4 0.7 <0.001
pBMI 4032 22.9 3.7 22.9 3.8 0.8
Age (years) 4032 31.9 4.4 30.2 5.1 <0.001
Education (years after primary school) 4001 10.0 3.6 8.5 3.9 <0.001
Ethnicity (% Dutch) 4024 69.0 50.5 <0.001
Parity (% nulliparous) 4032 57.5 57.5 1.0
Smoking during gestation (% smoker) 4032 8.3 10.4 0.02
25OHD = 25-hydroxyvitamin D, pBMI = pre-pregnancy BMI, N = number of women with data available on a given covariate
†P-value for difference between responders and non-responders, as tested by X2 for categorical variables and independent sample t-tests for continuous
variables
doi:10.1371/journal.pone.0133313.t001
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Table 2. Study population characteristics as a function of maternal 25-hydroxyvitamin D status in early pregnancy.
Variable N Maternal 25-Hydroxyvitamin D Status P-Value†
All Deﬁcient
(299nmol/L)
Insufﬁcient
(300-499
nmol/L)
Adequate
(500 nmol/
L) ‡
Mean SD Mean SD Mean SD Mean SD
Study sample (N)(%) 1882 334 (17.7) 390 (20.7) 1158 (61.5)
Maternal Factors
Season of 25 OHD sample (%) 1875 <0.001
-Summer 24.4 10.8*** 11.6*** 32.7
-Fall 19.9 14.1 18.6 22.1
-Winter 36.9 59.9 49.7 25.8
-Spring 18.8 15.3 20.1 19.3
pBMI (kg/m2) 1882 22.9 3.7 24.2*** 4.9 23.6*** 4.3 22.2 2.9 <0.001
Age (years) 1882 31.9 4.4 29.7*** 5.5 32.0 4.4 32.4 3.7 <0.001
Education (years after primary school) 1875 10.0 3.6 7.4*** 4.3 9.9*** 3.6 10.8 2.9 <0.001
Ethnicity (%) 1882 <0.001
-Dutch 1299 69.0 29.6*** 64.4*** 82.0
-African-descent 74 3.9 9.6 6.2 1.6
-Turkish 50 2.7 11.4 2.1 0.3
-Moroccan 89 4.7 19.8 3.8 0.7
-Other western 234 12.4 7.5 14.1 13.3
-Other non-western 136 7.2 22.2 9.5 2.2
Parity (% nulliparous) 1882 1082 57.5 47.9*** 56.7 60.5 <0.001
Smoking (% Non-smoker) 1882 1726 91.7 88.3** 89.7* 93.4 0.004
Vitamin D supplement use (% yes) 1643 640 39.0 25.8*** 32.1*** 44.2 <0.001
Child Factors
Gender (% male) 1882 918 48.8 48.2 49.5 48.7 0.9
Age (years) 1874 5.7 0.5 5.9*** 0.5 5.7* 0.5 5.7 0.5 <0.001
Height (cm) 1871 116.7 5.6 117.2 5.8 116.7 5.6 116.5 5.6 0.2
Duration breastfeeding (%) 1859 <0.001
-none 301 16.2 18.2*** 19.2 14.6
-<1 month 122 6.6 11.6 6.2 5.2
-1-3 months 497 26.7 28.6 23.6 27.2
-3-6 months 599 32.2 22.2 32.7 34.9
-6 months 340 18.3 19.5 18.2 18.0
Use of vitamin drops (% no) 1664 174 10.5 11.8 12.7 9.4 0.2
Sedentary time (hours) 1731 1.4 1.0 2.1*** 1.3 1.5*** 1.1 1.2 0.7 <0.001
25OHD = 25-hydroxyvitamin D, pBMI = pre-pregnancy BMI
Mean values signiﬁcantly different from reference:
*p<0.05,
**p<0.01,
***p<0.001
†P-value for differences between vitamin D categories, as tested by X2 for categorical variables, and ANOVA and independent sample t-tests for
continuous variables
‡Reference group
doi:10.1371/journal.pone.0133313.t002
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Additionally, an inverse relationship was observed between maternal 25OHD and offspring %
BF, but no interaction with pBMI was observed in this association or for any other outcomes.
A non-linear association between pBMI and maternal 25OHD was also observed.
Strengths and limitations
Although these results are promising, strong conclusions cannot be drawn at this time because
the main findings did not hold in the non-imputed C-peptide data. Data were imputed using
the best possible method available, via survival analysis, on the basis of child age, gender and
BMI. Additionally, the range of C-peptide values in the non-imputed data was narrower due to
the exclusion of all samples below 0.34 nmol/L which reduced the possibility of detecting an
association in this sensitivity analysis. Finally, there were trends for significant interaction in
Fig 2. The association betweenmaternal 25-hydroxyvitamin D concentration in early pregnancy and pre-pregnancy BMI. The association between
maternal 25-hydroxyvitamin D and pre-pregnancy BMI modeled using restricted cubic splines. Adjusted for maternal age (31.9 years) and maternal
education (10 years) and presented for Dutch ethnicity, nulliparous women and non-smokers
doi:10.1371/journal.pone.0133313.g002
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the non-imputed data despite the much smaller sample size. However, strong conclusions can
only be drawn from future research on this topic by using more sensitive C-peptide assays.
Ultimately, it is possible that young children suffer from increased insulin resistance when
exposed to both maternal overweight and low 25OHD in utero, but future studies are necessary
to confirm this.
The association between maternal 25OHD and child %BF also lost significance in the sensi-
tivity analyses. Therefore, it is not possible to rule out the presence of residual confounding in
the main analysis. However, the loss of significance could be the result of overcorrection in the
sensitivity analysis that included season and vitamin D supplement use because these two vari-
ables are determinants of vitamin D status. In the Dutch-only sensitivity analysis and the sensi-
tivity analysis excluding maternal co-morbidities, the lower extremes of maternal 25OHD and
the higher extremes of child %BF were excluded, which reduced the chance of detecting a sig-
nificant relationship. Additionally, the association was borderline non-significant and the effect
sizes were not dramatically altered from the main analysis, suggesting a loss of power may be
responsible for these results. Ultimately, the findings of the primary analysis are supported by
previous research (4, 9), however, additional studies investigating the mediating properties of
Table 3. Linear regression models of the association betweenmaternal 25-hydroxyvitamin D concentration in early pregnancy and cardio-meta-
bolic outcomes in 5–6 year old children (per 10 nmol/L increase of 25-hydroxyvitamin D) with testing for interaction with pre-pregnancy BMI.
Outcome N Mean of outcome
variable (SD)
Model 11 Model 22
ß 99%CI ß 99%CI
Cardio-vascular Function
SBP (mmHg) 1841 99.6 (8.2) -0.1 (-0.3, 0.01) -0.06 (-0.2, 0.09)
DBP (mmHg) 1834 57.5 (6.8) -0.2 (-0.3, -0.09) -0.08 (-0.2, 0.05)
HR (bpm) 1668 85.6 (10.8) -0.2 (-0.4, 0.008) -0.1 (-0.3, 0.1)
Adiposity
BMI (kg/m2) 1870 15.6 (1.7) -0.05 (-0.08, -0.02) -0.02 (-0.06, 0.007)
Body fat (%) 1843 20.8 (6.9) * - -0.1 (-0.3, -0.003)
WHtR 1869 0.45 (0.04) -0.001 (-0.002,-0.0004) -0.0006 (-0.001, 0.00007)
Lipid Proﬁle
TC (mmol/L) 1201 4.0 (0.8) 0.01 (-0.005, 0.03) 0.02 (-0.002, 0.04)
LDL-C (mmol/L) 1201 2.3 (0.8) 0.01 (-0.006, 0.03) 0.01 (-0.005, 0.03)
HDL-C (mmol/L) 1201 1.3 (0.4) -0.0005 (-0.008, 0.007) -0.0002 (-0.009, 0.009)
TG (mmol/L) 1201 0.65 (0.4) -0.002 (-0.009, 0.006) -0.0001 (-0.009, 0.009)
Glucose Metabolism
Glucose (mmol/L) 1201 4.6 (0.6) -0.002 (-0.01, 0.01) 0.0004 (-0.01, 0.01)
C-peptide (nmol/L) 898 0.35 (0.1) † - † -
HOMA2-IR 898 0.75 (0.3) † - † -
99%CI = 99% conﬁdence interval, bpm = beats per minute, DBP = diastolic blood pressure, HOMA2-IR = homeostatic model assessment of insulin
resistance, HDL-C = high density lipoprotein cholesterol, HR = heart rate, LDL-C = low density lipoprotein cholesterol, SBP = systolic blood pressure,
TC = total cholesterol, TG = triglyceride, WHtR = waist-to-height ratio
1adjusted for child age and gender (and child height for cardiovascular function outcomes);
2additionally adjusted for maternal education, ethnicity, maternal age, parity, smoking during gestation, duration of breastfeeding, use of vitamin D or A/D
drops in infancy and child’s sedentary time
*Signiﬁcant non-linear relationship presented in Fig 4
† Signiﬁcant interaction. Associations presented in Fig 3
doi:10.1371/journal.pone.0133313.t003
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season, supplement use and maternal co-morbidities in the relationship, as well as more studies
in non-Western ethnic groups are necessary to confirm the results of the current study.
The current study was also limited by selective drop-out because mothers whose children
completed follow-up had higher SES, were more often Dutch, and were less likely to have
smoked during pregnancy. Higher risk individuals were lost to follow-up, which may have
biased the results and possibly limited the strength of the observed effect sizes. Therefore addi-
tional research on this topic in higher risk populations is also necessary.
The current study benefited from a large sample size, corrections for testing multiple out-
comes and testing of non-linearity. 25OHD concentration was also measured early in preg-
nancy which is a critical period for the establishment of maternal tolerance to the embryo and
placenta [40]. Finally, we believe this was the first study to investigate interaction with pBMI in
the relationship between maternal 25OHD and child cardio-metabolic outcomes.
Potential biological mechanisms
A non-linear relationship between maternal 25OHD and pBMI was clearly observed in the cur-
rent study. The proportions of women with deficient 25OHD levels in early gestation were
greater in both the underweight and overweight women, suggesting that the observed parabolic
association was not simply a statistical artifact of the small number of underweight women.
Additionally, the observed non-linear relationship corresponds with previous research in preg-
nant and non-pregnant subjects [12, 13, 19]. In overweight individuals, dietary intake and sun
exposure may partially influence 25OHD levels, but sequestration in adipose tissue appears to
be the major mechanism [38, 41]. The mechanism in underweight women is less clear due to
Fig 3. The association betweenmaternal 25-hydroxyvitamin D concentration and insulin resistancemarkers in young children. The association
between maternal 25-hydroxyvitamin D concentration in early pregnancy and a) C-peptide and b) HOMA2-IR in 5–6 year old children with interaction with
pre-pregnancy BMI presented. Adjusted for maternal age (32.4 years), maternal education (10 years), child age (5.6 years) and sedentary time (1.4 hours),
and presented for Dutch ethnicity, nulliparous mothers, non-smokers, male children, no use of vitamin D or A/D drops in infancy and no history of
breastfeeding.
doi:10.1371/journal.pone.0133313.g003
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limited research in this population. It is possible that more 25OHD remains in the bloodstream
as a result of a lower fat mass, leading to faster elimination [12]. Alternatively, deficiency in
this population could result from poor dietary intake of vitamin D [42].
Although higher pBMIs are associated with lower maternal 25OHD in early gestation [13,
19], several studies have found no associations between pBMI and 25OHD in late gestation [9,
11, 20]. The reason for this inconsistency is unclear. Perhaps over the course of pregnancy, nor-
mal weight women gain proportionally more adipose tissue than overweight women, resulting
in comparable sequestration of 25OHD [17]. Despite this, fetuses receive less 25OHD from
Fig 4. The association betweenmaternal 25-hydroxyvitamin D concentration and percentage body fat in young children. The association between
maternal 25-hydroxyvitamin D concentration and percentage body fat in 5–6 year old children, per model 1 (adjusted for child age (5.7 years) and presented
for male children).
doi:10.1371/journal.pone.0133313.g004
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overweight women [19, 20], perhaps due to 25OHD sequestration in adipose tissue early in
pregnancy and impaired 25OHD transfer later in pregnancy. In human and animals models of
obesity during pregnancy, alterations in placental structure as well as increased placental
inflammation have been observed, both of which could contribute to placental dysfunction [16,
43]. Dysregulation of vitamin D metabolism has also been associated with alterations in pla-
cental inflammatory pathways [40, 44] and vitamin D deficiency in rat dams has been associ-
ated with abnormal placental vascularization [44]. Thus it is possible that an elevated pBMI
leads to both placental dysfunction and maternal 25OHD deficiency, which in itself contributes
to placental dysfunction, ultimately impairing 25OHD transfer to the fetus. However, more
research is necessary to fully understand the mechanisms involved.
The inverse associations observed between maternal 25OHD and IR markers in children of
overweight women are logical when considering the current evidence. When studied sepa-
rately, both 25OHD and maternal overweight have been related to diabetes mellitus. Over-
weight during pregnancy appears to increase the risk for type 2 diabetes mellitus in offspring
[16–18] by contributing to placental inflammation and causing excessive nutrient transfer to
the fetus [16]. 25OHD deficiency within individuals is associated with an increased risk of type
2 diabetes mellitus [45], possibly via influence on beta cell function and insulin sensitivity [5,
46]. Additionally, recent work in rats has shown that vitamin D deficient dams give birth to
insulin resistant pups and that this IR worsens as the pups age [7]. The results of this study
appear to be related to epigenetic mechanisms that are mediated by maternal 25OHD and
which subsequently promote inflammation in the offspring [7]. Perhaps in humans the combi-
nation of low maternal 25OHD and overweight are sufficient to alter glucose metabolism in
offspring leading to the development of IR.
Similar relationships between maternal 25OHD and IR in the children of underweight
mothers were not observed, but a slight trend could be seen on graphical analysis (Fig 3). If an
inverse association between maternal 25OHD and offspring IR exists for this group, the mech-
anisms may involve restricted fetal growth. Both low maternal 25OHD and maternal under-
weight have been associated with lower birth weight [13, 14] and lower birth weight has been
associated with an increased risk of type 2 diabetes mellitus [1, 47]. Unfortunately, little can be
concluded about this group of mothers and children because of the limited research.
The inverse association observed between maternal 25OHD and child %BF is also consis-
tent with previous observations [4, 9]. There is some evidence that the 25OHDmetabolite,
1,25-dihydroxyvitamin D, may directly influence offspring lipid storage and metabolism, and
25OHDmay also be involved in normal offspring muscle development, which could influence
the proportion of fat- to fat-free mass [48]. No interaction with pBMI was observed for this
association, suggesting that lower 25OHD is associated with increases in offspring body fat but
that the combined exposure of low 25OHD and abnormal pBMI does not result in even higher
offspring adiposity. Perhaps 25OHD functions as a mediator in the relationship between pBMI
and offspring body fat, however further investigations are necessary to confirm this hypothesis.
Previous research
The results of this study may help to clarify inconsistencies from previous research [4, 9–11].
Williams et al. [11] did not observe an inverse association between maternal 25OHD and off-
spring IR markers, while Krishnaveni et al. did [4]. Perhaps differences in pBMIs and the eth-
nic compositions of these two cohorts contributed to the disparate findings. Williams et al.
[11] also observed an inverse association between maternal 25OHD and SBP in ten year old
children, but the finding was not highly significant, nor was it observed in the current research
or in other studies [4, 10]. Thus, the possibility of type I error cannot be ruled out. Our
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observation of an inverse relationship between maternal 25OHD and child %BF was similar to
the results from Crozier et al. and Krishnaveni et al., but contrary to those from Gale et al. [4, 9,
10]. It is possible, however, that Gale et al. did not detect this association due to the small sam-
ple size (N = 178) [10]. Finally, the lack of associations with the remaining cardio-metabolic
outcomes in the current study appears to be in line with previous research [4, 9–11] indicating
that if maternal 25OHD affects cardio-metabolic health of offspring, the effects are limited to
body composition and glucose metabolism.
Implications
As stated previously, strong conclusions cannot be drawn from these results due to the limita-
tions of the undetectable C-peptide data. However, future research in overweight women may
help to confirm whether an inverse relationship between maternal 25OHD and offspring IR
exists for this population. Additionally, while limited by possible residual confounding, the
observed association between maternal 25OHD and offspring adiposity has been observed in
the previous literature [4, 9]. Perhaps offspring %BF could be investigated as an outcome in
some of the many vitamin D supplementation trials in pregnant women that are currently
underway [49] to help clarify if there is indeed a causal relationship between maternal 25OHD
and child adiposity.
Conclusions
The results of this study suggest that low maternal 25OHD is associated with increased IR in
the children of overweight women, and that low maternal 25OHD is associated with increased
%BF in children with no interactive effects from pBMI. Due to the limitations of this study,
these results are not conclusive, however the observations of this study pose important research
questions for future studies to investigate.
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